P. vivax Malaria Renaissance: Pharmaceutical Breakthroughs and Market Resilience
  The pharmaceutical sector's renewed focus on Plasmodium vivax malaria has ushered in an era of unprecedented innovation and market dynamism. This once-neglected pathogen, affecting approximately 2.85 billion people at risk globally, has become a catalyst for revolutionary therapeutic development and strategic market positioning that promises to reshape tropical disease management...
0 Comentários 0 Compartilhamentos 3K Visualizações 0 Anterior
flexartsocial.com https://www.flexartsocial.com